AREDIA Drug Patent Profile
✉ Email this page to a colleague
When do Aredia patents expire, and what generic alternatives are available?
Aredia is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in AREDIA is pamidronate disodium. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the pamidronate disodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aredia
A generic version of AREDIA was approved as pamidronate disodium by HIKMA on April 30th, 2001.
Summary for AREDIA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 85 |
Clinical Trials: | 12 |
Patent Applications: | 3,829 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AREDIA at DailyMed |
Recent Clinical Trials for AREDIA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ottawa Hospital Research Institute | Phase 4 |
Masonic Cancer Center, University of Minnesota | Phase 2 |
Amgen | Phase 4 |
US Patents and Regulatory Information for AREDIA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | AREDIA | pamidronate disodium | INJECTABLE;INJECTION | 020036-001 | Oct 31, 1991 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novartis | AREDIA | pamidronate disodium | INJECTABLE;INJECTION | 020036-003 | May 6, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novartis | AREDIA | pamidronate disodium | INJECTABLE;INJECTION | 020036-004 | May 6, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for AREDIA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | AREDIA | pamidronate disodium | INJECTABLE;INJECTION | 020036-001 | Oct 31, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
Novartis | AREDIA | pamidronate disodium | INJECTABLE;INJECTION | 020036-004 | May 6, 1993 | ⤷ Try a Trial | ⤷ Try a Trial |
Novartis | AREDIA | pamidronate disodium | INJECTABLE;INJECTION | 020036-001 | Oct 31, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
Novartis | AREDIA | pamidronate disodium | INJECTABLE;INJECTION | 020036-004 | May 6, 1993 | ⤷ Try a Trial | ⤷ Try a Trial |
Novartis | AREDIA | pamidronate disodium | INJECTABLE;INJECTION | 020036-003 | May 6, 1993 | ⤷ Try a Trial | ⤷ Try a Trial |
Novartis | AREDIA | pamidronate disodium | INJECTABLE;INJECTION | 020036-003 | May 6, 1993 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for AREDIA
See the table below for patents covering AREDIA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Netherlands | 7414947 | ⤷ Try a Trial | |
Spain | 555602 | ⤷ Try a Trial | |
Argentina | 244698 | PROCEDIMIENTO PARA OBTENER UNA NUEVA MODIFICACION CRISTALINA DEL 3-AMINO-1-HIDROXI-1,1-DIFOSFONATO DISODICO. (CRYSTAL MODIFICATION OF DISODIUM-3-AMINO-1-HYDROXY-PROPANE-1,1- DIPHOSPHONATE) | ⤷ Try a Trial |
Denmark | 167282 | ⤷ Try a Trial | |
Italy | 1058296 | PREPARATO COSEMTICO A BASE DI AGENTI PER LA CURA DELLA BOCCA E DEI DENTI CHE CONTENGONO UN ACIDO AMMINOALCAREDIFOSFONICO OPPURE I SUOI SALI IDROSOLUBILI | ⤷ Try a Trial |
Norway | 165401 | ⤷ Try a Trial | |
Hong Kong | 42591 | CRYSTAL MODIFICATION OF DISODIUM-3-AMINO-1-HYDROXY-PROPANE-1,1-DIPHOSPHONATE | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |